Status:
UNKNOWN
Establishment and Clinical Validation of New Technologies for Accurate Screening of Colorectal Cancer Based on Multi-omics
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Colorectal Cancer
Eligibility:
All Genders
40-74 years
Brief Summary
Background: The current screening techniques for colorectal cancer include colonoscopy, fecal occult blood, and high-risk factor questionnaires. However, the colorectal cancer screening technology th...
Eligibility Criteria
Inclusion
- Age: 40-74 years old
Exclusion
- Combine severe disorders to make it unsuitable for colonoscopy
- Combine other tumors
- Mental and behavioral abnormalities do not cooperate with the screener
- Researchers believe that other reasons are not suitable for enrollment
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
9000 Patients enrolled
Trial Details
Trial ID
NCT04913233
Start Date
July 1 2021
End Date
November 1 2024
Last Update
June 4 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese Medicine Hospital of Haining City, Haining Cancer Preventional and Treatment Research Institute
Haining, Zhejiang, China, 314400
2
Jiashan County Cancer Prevention and Treatment Institute
Jiashan, Zhejiang, China, 314100
3
Lanxi City People's Hospital, Linjiang Hospital
Lanxi, Zhejiang, China, 321100